Prospective Short-Term Effects of Glucocorticoid Treatment on Glucose and Lipid Metabolism in Japanese

スポンサーリンク

概要

• 論文の詳細を見る

• Objective Glucocorticoid (GC) causes various metabolic abnormalities; however, few prospective studies have examined the changes in glucose and lipid metabolism in newly GC-treated patients. Methods and Patients The present study was therefore performed to analyze markers of glucose and lipid metabolism on days 0, 3, 7, 14, 28 and at month 3 of treatment in patients starting GC therapy. Then, we analyzed the relationships between the changes in these parameters and the initial dose of prednisolone (PSL), separating groups into different regimens by the GC dose. Results The fasting plasma glucose (FPG) level transiently increased on day 3 of PSL administration but was restored by day 7. The immunoreactive insulin (IRI) level and HOMA-R transiently increased on day 3 and then fell, although remaining significantly higher than each basal level by day 7. A transient elevation in FPG level on day 3 was observed only in groups with a PSL dose ≥40 mg. On the other hand, total cholesterol and low-density lipoprotein cholesterol levels increased on day 3 of PSL administration and similar levels were maintained after day 7. High density-lipoprotein cholesterol levels were significantly increased on day 3; subsequently then gradually increased from days 3 to day 28. Triglyceride levels did not change during treatment. No relationship was apparent between the GC dose and the changes in each lipid parameter. Conclusion GC treatment induced changes in FPG, IRI, LDL-CHOL and HDL-CHOL levels from day 3 after start of GC. The dose of GC seemed to influence glucose metabolism, but not lipid metabolism.

著者

• Kawano Seiji

  Clinical Laboratory Kobe University Hospital

• Kanda Fumio

  Division Of Diabetes Metabolism And Endocrinology Department Of Internal Medicine Kobe University Gr

• Sugimoto Toshitsugu

  Internal Medicine 1 Shimane University Faculty Of Medicine

• Kuroki Yasuo

  Internal Medicine Kobe Century Memorial Hospital

• Takai Yutaka

  Internal Medicine Kobe Rehabilitation Hospital

• Kaji Hiroshi

  Division Of Diabetes And Endocrinology Department Of Internal Medicine Kobe University Graduate Scho

• Kajikawa Michiko

  Division of Internal Medicine, Yodogawa Christian Hospital

関連論文

• The Lipoprotein Fraction between VLDL and LDL Detected by Biphasic Agarose Gel Electrophoresis Reflects Serum Remnant Lipoprotein and Lp(a) Concentrations
• Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis
• Hepatic Failure and Enhanced Oxidative Stress in Mitochondrial Diabetes
• Multifocal Fibrosclerosis as a Possible Cause of Panhypopituitarism with Central Diabetes Insipidus
• Vitamin D Status Affects Osteopenia in Postmenopausal Patients with Primary Hyperparathyroidism
• A case of primary hyperparathyroidism with marked changes in bone mineral density and geometry after parathyroidectomy
• The Threshold of Bone Mineral Density for Vertebral Fracture in Female Patients with Glucocorticoid-induced Osteoporosis
• Effects of Age, Grip Strength and Smoking on Forearm Volumetric Bone Mineral Density and Bone Geometry by Peripheral Quantitative Computed Tomography : Comparisons between Female and Male
• Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells
• Trial to Predict Malignancy of Affected Parathyroid Glands in Primary Hyperparathyroidism
• Functional Giant Parathyroid Cyst with High Concentration of CA19-9 in Cystic Fluid
• Factors Affecting Bone Mineral Density in Hemodialysis Patients with Diabetic Nephropathy
• Prospective Short-Term Effects of Glucocorticoid Treatment on Glucose and Lipid Metabolism in Japanese
• Bisphosphonate-related osteonecrosis of the jaw : position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillof
• Focal Myositis in Monozygotic Twins
• Measurement of Platelet-derived Microparticle Levels in the Chronic Phase of Cerebral Infarction Using an Enzyme-linked Immunosorbent Assay
• Subacute Bulbar Palsy as the Initial Sign of Follicular Thyroid Cancer
• Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients : a prospective study
• Effect of Contrast Material (Levovist) Infusion on Peak Systolic Velocity in Middle Cerebral Artery Using Transcranial Color-Coded Duplex Sonography
• Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D_3 load in Japanese subjects
• Elcatonin is effective for lower back pain and the symptoms of gastroesophageal reflux disease in elderly osteoporotic patients with kyphosis
• Caspase 8 and menin expressions are not correlated in human parathyroid tumors
• Bone metabolism and fracture risk in type 2 diabetes mellitus
• Partial Improvement of Anterior Pituitary Deficiency Following Steroid Treatment in a Patient with Neurosarcoidosis Accompanied by Central Diabetes Insipidus
• Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone
• Smad7 inhibits differentiation and mineralization of mouse osteoblastic cells
• The Effect of Pramipexole on Depressive Symptoms in Parkinson's Disease.
• Severe Hypophosphatemic Osteomalacia with Fanconi Syndrome, Renal Tubular Acidosis, Vitamin D Deficiency and Primary Biliary Cirrhosis
• McCune-Albright Syndrome with Acromegaly and Fibrous Dysplasia Associated with the GNAS Gene Mutation Identified by Sensitive PNA-clamping Method
• Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia
• Diagnostic criteria for primary osteoporosis : year 2012 revision
• Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes
• Molecular pathology of Sandhoff disease with p.Arg505Gln in HEXB : application of simulation analysis

もっと見る 閉じる

スポンサーリンク